Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Apr;35(4):847–852. doi: 10.1128/jcm.35.4.847-852.1997

Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex.

A Ambaye 1, P C Kohner 1, P C Wollan 1, K L Roberts 1, G D Roberts 1, F R Cockerill 3rd 1
PMCID: PMC229688  PMID: 9157140

Abstract

An evaluation was undertaken to determine the optimal method for the in vitro susceptibility testing of 26 Nocardia asteroides complex isolates to the following antimicrobial agents: amikacin, ampicillin, amoxicillin-clavulanate, ceftriaxone, ciprofloxacin, erythromycin, imipenem, minocycline, and trimethoprim-sulfamethoxazole. Five testing methods were studied including the agar dilution, broth microdilution, and disk diffusion methods, the epsilometer test (E-test), and the BACTEC radiometric method. Results for each antimicrobial agent and each testing method were interpreted as indicating susceptibility, intermediate susceptibility, or resistance according to current guidelines of the National Committee for Clinical Laboratory Standards (NCCLS) for bacteria that grow aerobically and were then compared to a "gold standard" susceptibility test result. The gold standard result for each Nocardia isolate was established by a consensus of the results of the majority of testing methods used in the study. When the results were combined for all antimicrobial agents tested against all Nocardia isolates by all methods, the BACTEC radiometric method produced the highest level of agreement (97.9%) with the consensus results and had the fewest very major (n = 1), major (n = 2), and minor (n = 2) errors. In contrast, the results of the agar dilution method were in least agreement (93.2%) with the consensus results, and this method also produced the most very major (n = 8), major (n = 4), and, along with the disk diffusion method, minor (n = 6) errors. For all test methods, interpretive errors were most frequent when testing ampicillin or amoxicillin-clavulanate. Moreover, for all Nocardia nova isolates tested, ampicillin susceptibility results by any of the testing methods were not in agreement with the results of testing for beta-lactamase by the nitrocefin (Cefinase) disk method. We conclude that among the methods evaluated, the BACTEC radiometric method appeared to be the best for determining the in vitro susceptibilities of members of the N. asteroides complex to a panel of nine antimicrobial agents. However, none of the test methods, including the BACTEC method, accurately predicted the ampicillin resistance of the N. nova isolates tested, all of which produced beta-lactamase. Presuming that this beta-lactamase hydrolyzes ampicillin, this disparity may relate to the NCCLS breakpoints that were used, which may require modification for this antimicrobial agent when tested against N. nova isolates.

Full Text

The Full Text of this article is available as a PDF (89.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biehle J. R., Cavalieri S. J., Saubolle M. A., Getsinger L. J. Comparative evaluation of the E test for susceptibility testing of Nocardia species. Diagn Microbiol Infect Dis. 1994 Jun;19(2):101–110. doi: 10.1016/0732-8893(94)90120-1. [DOI] [PubMed] [Google Scholar]
  2. Cockerill F. R., 3rd, Edson R. S., Roberts G. D., Waldorf J. C. Trimethoprim/sulfamethoxazole-resistant Nocardia asteroides causing multiple hepatic abscesses. Successful treatment with ampicillin, amikacin, and limited computed tomography-guided needle aspiration. Am J Med. 1984 Sep;77(3):558–560. doi: 10.1016/0002-9343(84)90121-9. [DOI] [PubMed] [Google Scholar]
  3. Dewsnup D. H., Wright D. N. In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents. Antimicrob Agents Chemother. 1984 Feb;25(2):165–167. doi: 10.1128/aac.25.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fried J., Hinthorn D., Ralstin J., Gerjarusak P., Liu C. Cure of brain abscess caused by Nocardia asteroides resistant to multiple antibiotics. South Med J. 1988 Mar;81(3):412–413. doi: 10.1097/00007611-198803000-00033. [DOI] [PubMed] [Google Scholar]
  5. Goldstein F. W., Hautefort B., Acar J. F. Amikacin-containing regimens for treatment of nocardiosis in immunocompromised patients. Eur J Clin Microbiol. 1987 Apr;6(2):198–200. doi: 10.1007/BF02018213. [DOI] [PubMed] [Google Scholar]
  6. Kitzis M. D., Gutmann L., Acar J. F. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content. J Antimicrob Chemother. 1985 Jan;15(1):23–30. doi: 10.1093/jac/15.1.23. [DOI] [PubMed] [Google Scholar]
  7. Petersen E. A., Nash M. L., Mammana R. B., Copeland J. G. Minocycline treatment of pulmonary nocardiosis. JAMA. 1983 Aug 19;250(7):930–932. [PubMed] [Google Scholar]
  8. Scopetti F., Iona E., Fattorini L., Goglio A., Franceschini N., Amicosante G., Orefici G. Activity of antimicrobial drugs evaluated by agar dilution and radiometric methods against strains of Nocardia asteroides isolated in Italy from immunocompromised patients. J Chemother. 1994 Feb;6(1):29–34. doi: 10.1080/1120009x.1994.11741125. [DOI] [PubMed] [Google Scholar]
  9. Steingrube V. A., Wallace R. J., Jr, Brown B. A., Zhang Y., Steele L. C., Young G., Nash D. R. Partial characterization of Nocardia farcinica beta-lactamases. Antimicrob Agents Chemother. 1993 Sep;37(9):1850–1855. doi: 10.1128/aac.37.9.1850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wallace R. J., Jr, Brown B. A., Tsukamura M., Brown J. M., Onyi G. O. Clinical and laboratory features of Nocardia nova. J Clin Microbiol. 1991 Nov;29(11):2407–2411. doi: 10.1128/jcm.29.11.2407-2411.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wallace R. J., Jr, Septimus E. J., Musher D. M., Martin R. R. Disk diffusion susceptibility testing of Nocardia species. J Infect Dis. 1977 Apr;135(4):568–576. doi: 10.1093/infdis/135.4.568. [DOI] [PubMed] [Google Scholar]
  12. Wallace R. J., Jr, Steele L. C., Sumter G., Smith J. M. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother. 1988 Dec;32(12):1776–1779. doi: 10.1128/aac.32.12.1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wallace R. J., Jr, Steele L. C. Susceptibility testing of Nocardia species for the clinical laboratory. Diagn Microbiol Infect Dis. 1988 Mar;9(3):155–166. doi: 10.1016/0732-8893(88)90025-9. [DOI] [PubMed] [Google Scholar]
  14. Wallace R. J., Jr, Vance P., Weissfeld A., Martin R. R. Beta-lactamase production and resistance to beta-lactam antibiotics in Nocardia. Antimicrob Agents Chemother. 1978 Nov;14(5):704–709. doi: 10.1128/aac.14.5.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Zeger S. L., Liang K. Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986 Mar;42(1):121–130. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES